GlassScriptPhysician profile
Jacob W Phillips
NPI 1730317868
$1,718.21
in general payments reported to CMS, 2019-2025
17 companies · $687 in 2025
The $687 reported for 2025 was more than what 88% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $210 · 2024: $822 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.72 | 2023-2025 | |
| Novo Nordisk INC | $418.48 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $192.07 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $183.28 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.09 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $101.66 | 2024-2025 | |
| Edwards Lifesciences Corporation | $49.54 | 2023-2024 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $38.63 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $30.29 | 2024 | Voquezna |
| Alk-Abello, INC | $25.50 | 2024 | Odactra, Ragwitek, Grastek |
| Exact Sciences Corporation | $22.76 | 2025 | Cologuard Collection Kit |
| Seqirus USA INC | $21.10 | 2024 | Flucelvax, Fluad |
| Amphastar Pharmaceuticals, INC. | $18.19 | 2025 | |
| Merck Sharp & Dohme LLC | $17.26 | 2024 | Vaxelis, Capvaxive, Gardasil |
| Insulet Corporation | $15.89 | 2024 | Omnipod |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.96 | 2025 | Caplyta |
| Corium, LLC | $10.79 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.